Article
Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.
Journal of biomedicine & biotechnology - 1 Jan 2012
Silk Kathryn M, Leishman Alison J, Nishimoto Kevin P, Reddy Anita, Fairchild Paul J
Abstract excerpt
While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the establishment of immunological tolerance, we have proposed that DC, rendered tolerogenic during their differentiation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
